Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 7 studies | 19% ± 4% |
Insufficient scRNA-seq data for expression of NACAD at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 5030.82 | 2641 / 2642 | 100% | 52.04 | 703 / 705 |
ovary | 100% | 1618.09 | 180 / 180 | 65% | 6.26 | 279 / 430 |
prostate | 91% | 867.94 | 223 / 245 | 39% | 1.92 | 194 / 502 |
uterus | 98% | 1652.49 | 167 / 170 | 29% | 3.70 | 133 / 459 |
bladder | 86% | 945.10 | 18 / 21 | 17% | 1.37 | 84 / 504 |
blood vessel | 98% | 1373.05 | 1311 / 1335 | 0% | 0 | 0 / 0 |
breast | 76% | 560.93 | 349 / 459 | 22% | 1.23 | 241 / 1118 |
esophagus | 64% | 964.30 | 929 / 1445 | 28% | 2.10 | 52 / 183 |
adrenal gland | 17% | 182.73 | 44 / 258 | 70% | 49.17 | 161 / 230 |
kidney | 40% | 222.33 | 36 / 89 | 46% | 3.57 | 410 / 901 |
intestine | 75% | 1062.22 | 720 / 966 | 9% | 0.62 | 48 / 527 |
lung | 58% | 352.30 | 338 / 578 | 22% | 1.58 | 258 / 1155 |
adipose | 73% | 532.95 | 880 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 69% | 4.96 | 55 / 80 |
heart | 66% | 450.48 | 565 / 861 | 0% | 0 | 0 / 0 |
stomach | 48% | 532.59 | 171 / 359 | 14% | 1.03 | 41 / 286 |
pancreas | 0% | 0 | 0 / 328 | 58% | 5.64 | 104 / 178 |
skin | 19% | 99.32 | 341 / 1809 | 38% | 3.59 | 181 / 472 |
thymus | 14% | 80.57 | 94 / 653 | 27% | 1.79 | 166 / 605 |
spleen | 23% | 129.99 | 56 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 7% | 0.42 | 3 / 45 |
liver | 0% | 0 | 0 / 226 | 2% | 0.09 | 9 / 406 |
muscle | 1% | 6.73 | 11 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0015031 | Biological process | protein transport |
GO_0006612 | Biological process | protein targeting to membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005854 | Cellular component | nascent polypeptide-associated complex |
GO_0005634 | Cellular component | nucleus |
GO_0051082 | Molecular function | unfolded protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | NACAD |
Protein name | NAC-alpha domain-containing protein 1 |
Synonyms | KIAA0363 |
Description | FUNCTION: May prevent inappropriate targeting of non-secretory polypeptides to the endoplasmic reticulum (ER). May bind to nascent polypeptide chains as they emerge from the ribosome and block their interaction with the signal recognition particle (SRP), which normally targets nascent secretory peptides to the ER. May also reduce the inherent affinity of ribosomes for protein translocation sites in the ER membrane (M sites) (By similarity). . |
Accessions | O15069 ENST00000490531.3 |